Noveris Health Sciences Inc. (CSE:NVRS)

Market Cap	216.14K -76.7%
Revenue (ttm)	n/a
Net Income	2.29M
EPS	1.85
Shares Out	1.24M
PE Ratio	0.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	3,082
Open	0.2000
Previous Close	n/a
Day's Range	0.1750 - 0.2000
52-Week Range	0.1200 - 0.5000
Beta	2.34
RSI	39.99
Earnings Date	Mar 31, 2026

About Noveris Health Sciences

Noveris Health Sciences Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Mydecine Innovations Gr...

• Industry: Agricultural Production Crops
• Founded: 2013
• Employees: 3
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: NVRS